Barletta, F.; Tappero, S.; Panunzio, A.; Incesu, R.-B.; Cano Garcia, C.; Piccinelli, M.L.; Tian, Z.; Gandaglia, G.; Moschini, M.; Terrone, C.;
et al. Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype. Cancers 2022, 14, 5766.
https://doi.org/10.3390/cancers14235766
AMA Style
Barletta F, Tappero S, Panunzio A, Incesu R-B, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C,
et al. Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype. Cancers. 2022; 14(23):5766.
https://doi.org/10.3390/cancers14235766
Chicago/Turabian Style
Barletta, Francesco, Stefano Tappero, Andrea Panunzio, Reha-Baris Incesu, Cristina Cano Garcia, Mattia Luca Piccinelli, Zhe Tian, Giorgio Gandaglia, Marco Moschini, Carlo Terrone,
and et al. 2022. "Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype" Cancers 14, no. 23: 5766.
https://doi.org/10.3390/cancers14235766
APA Style
Barletta, F., Tappero, S., Panunzio, A., Incesu, R.-B., Cano Garcia, C., Piccinelli, M. L., Tian, Z., Gandaglia, G., Moschini, M., Terrone, C., Antonelli, A., Tilki, D., Chun, F. K. H., de Cobelli, O., Saad, F., Shariat, S. F., Montorsi, F., Briganti, A., & Karakiewicz, P. I.
(2022). Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype. Cancers, 14(23), 5766.
https://doi.org/10.3390/cancers14235766
